2018年(nian)(nian)全國藥(yao)(yao)(yao)(yao)品(pin)(pin)不良反(fan)(fan)應(ying)監(jian)測網(wang)絡收到新的(de)(de)和(he)嚴重(zhong)藥(yao)(yao)(yao)(yao)品(pin)(pin)不良反(fan)(fan)應(ying)/事件(jian)報(bao)(bao)(bao)告(gao)(gao)49.5萬份(fen)；新的(de)(de)和(he)嚴重(zhong)藥(yao)(yao)(yao)(yao)品(pin)(pin)不良反(fan)(fan)應(ying)/事件(jian)報(bao)(bao)(bao)告(gao)(gao)占同期報(bao)(bao)(bao)告(gao)(gao)總數的(de)(de)33.1%。新的(de)(de)和(he)嚴重(zhong)藥(yao)(yao)(yao)(yao)品(pin)(pin)不良反(fan)(fan)應(ying)/事件(jian)報(bao)(bao)(bao)告(gao)(gao)比例(li)持(chi)續(xu)增加，顯示我(wo)國藥(yao)(yao)(yao)(yao)品(pin)(pin)不良反(fan)(fan)應(ying)報(bao)(bao)(bao)告(gao)(gao)可利用性(xing)(xing)持(chi)續(xu)增加。2018年(nian)(nian)藥(yao)(yao)(yao)(yao)品(pin)(pin)不良反(fan)(fan)應(ying)/事件(jian)報(bao)(bao)(bao)告(gao)(gao)中，男女患者比為0.86:1，女性(xing)(xing)略多(duo)于男性(xing)(xing)。14歲以下兒(er)童患者的(de)(de)報(bao)(bao)(bao)告(gao)(gao)占9.8%；65歲以上(shang)老(lao)年(nian)(nian)患者的(de)(de)報(bao)(bao)(bao)告(gao)(gao)占27.7%，因此國家(jia)藥(yao)(yao)(yao)(yao)品(pin)(pin)監(jian)督管(guan)理局(ju)整理2019年(nian)(nian)最新兒(er)童禁藥(yao)(yao)(yao)(yao)名單。

2019年兒童(tong)(tong)(tong)(tong)(tong)用(yong)藥(yao)(yao)黑名單中分為(wei)(wei)感(gan)冒藥(yao)(yao)、心腦(nao)血管藥(yao)(yao)、腸胃道疾病用(yong)藥(yao)(yao)、跌打損傷/骨科用(yong)藥(yao)(yao)、中藥(yao)(yao)注射劑等類型藥(yao)(yao)物(wu)。我國3500多種(zhong)藥(yao)(yao)品(pin)制劑中，兒童(tong)(tong)(tong)(tong)(tong)專用(yong)劑型僅(jin)1.7%，這(zhe)說明我國專為(wei)(wei)兒童(tong)(tong)(tong)(tong)(tong)生產(chan)藥(yao)(yao)品(pin)的企(qi)業少之又少，很多成人用(yong)藥(yao)(yao)兒童(tong)(tong)(tong)(tong)(tong)不能服用(yong)，因此(ci)整理出了相關2019年兒童(tong)(tong)(tong)(tong)(tong)禁用(yong)藥(yao)(yao)物(wu)。